Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study
- PMID: 20616292
- DOI: 10.3122/jabfm.2010.04.090299
Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study
Abstract
Background: Because comorbid depression can complicate medical conditions (eg, diabetes), physicians may treat depression more aggressively in patients who have these conditions. This study examined whether primary care physicians prescribe antidepressant medications more often and in higher doses for persons with medical comorbidities.
Methods: This secondary data analysis of electronic health record data was conducted in the Centricity Health Care User Research Network (CHURN), a national network of ambulatory practices that use a common outpatient electronic health record. Participants included 209 family medicine and general internal medicine providers in 40 primary care CHURN offices in 17 US states. Patients included adults with a new episode of depression that had been diagnosed during the period October 2006 through July 2007 (n = 1513). Prescription of antidepressant medication and doses of antidepressant medication were compared for patients with and without 6 comorbid conditions: diabetes, coronary heart disease, congestive heart failure, cerebrovascular disease, chronic obstructive pulmonary disease, and cancer.
Results: 20.7% of patients had at least one medical comorbidity whereas 5.8% had multiple comorbidities. Overall, 77% of depressed patients were prescribed antidepressant medication. After controlling for age and sex, patients with multiple comorbidities were less likely to be prescribed medication (adjusted odds ratio, 0.58; 95% CI, 0.35-0.96), but there was no significant difference by individual comorbidities. Patients with cerebrovascular disease were less likely to be prescribed a full dose of medication (adjusted odds ratio, 0.26; 95% CI, 0.08-0.88), but there were no differences for other comorbidities or for multiple comorbidities, and there was no difference for any comorbidities in the prescription of minimally effective doses.
Conclusions: Patients with new episodes of depression who present to a primary care practice are not treated more aggressively if they have medical comorbidities. In fact, patients with multiple comorbidities are treated somewhat less aggressively.
Similar articles
-
Depression diagnoses and antidepressant use in primary care practices: a study from the Practice Partner Research Network (PPRNet).J Fam Pract. 2000 Jan;49(1):68-72. J Fam Pract. 2000. PMID: 10678342
-
Management of depression in ambulatory care for patients with medical co-morbidities: a study from a national Electronic Health Record (EHR) network.Int J Psychiatry Med. 2008;38(2):203-15. doi: 10.2190/PM.38.2.g. Int J Psychiatry Med. 2008. PMID: 18724571
-
The treatment of depression: prescribing practices of primary care physicians and psychiatrists.J Fam Pract. 1992 Dec;35(6):627-35. J Fam Pract. 1992. PMID: 1360490
-
The impact of comorbid [corrected] conditions on critical illness.Crit Care Med. 2011 Dec;39(12):2728-35. doi: 10.1097/CCM.0b013e318236f27e. Crit Care Med. 2011. PMID: 22094497 Review.
-
Comorbidities of chronic obstructive pulmonary disease.Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S21-8. doi: 10.1097/01.mcp.0000410744.75216.d0. Curr Opin Pulm Med. 2011. PMID: 22209926 Review.
Cited by
-
General practice management of depression among patients with coronary heart disease in Australia.BMC Prim Care. 2022 Dec 16;23(1):329. doi: 10.1186/s12875-022-01938-x. BMC Prim Care. 2022. PMID: 36526976 Free PMC article.
-
A Bayesian nonparametric approach for inferring drug combination effects on mental health in people with HIV.Biometrics. 2022 Sep;78(3):988-1000. doi: 10.1111/biom.13508. Epub 2021 Jul 9. Biometrics. 2022. PMID: 34145900 Free PMC article.
-
The Antidepressant Mirtazapine Activates Hepatic Macrophages, Facilitating Pathogen Clearance While Limiting Tissue Damage in Mice.Front Immunol. 2020 Nov 3;11:578654. doi: 10.3389/fimmu.2020.578654. eCollection 2020. Front Immunol. 2020. PMID: 33250892 Free PMC article.
-
Defining Major Depressive Disorder Cohorts Using the EHR: Multiple Phenotypes Based on ICD-9 Codes and Medication Orders.Neurol Psychiatry Brain Res. 2020 Jun;36:18-26. doi: 10.1016/j.npbr.2020.02.002. Epub 2020 Feb 21. Neurol Psychiatry Brain Res. 2020. PMID: 32218644 Free PMC article.
-
The Antidepressant Mirtazapine Inhibits Hepatic Innate Immune Networks to Attenuate Immune-Mediated Liver Injury in Mice.Front Immunol. 2019 Apr 12;10:803. doi: 10.3389/fimmu.2019.00803. eCollection 2019. Front Immunol. 2019. PMID: 31031775 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical